208 related articles for article (PubMed ID: 28839440)
21. Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma.
Chi KH; Liu SJ; Li CP; Kuo HP; Wang YS; Chao Y; Hsieh SL
J Immunother; 2005; 28(2):129-35. PubMed ID: 15725956
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy.
Li N; Feng S; Xue J; Wei XB; Shi J; Guo WX; Lau WY; Wu MC; Cheng SQ; Meng Y
HPB (Oxford); 2016 Jun; 18(6):549-56. PubMed ID: 27317960
[TBL] [Abstract][Full Text] [Related]
23. [The preliminary study of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma patients with portal vein tumor thrombus].
Wang CG; Wang XL; Gong GQ; Chen G; Zeng ZC; Qiu WL; Lin GL; Chen Y; Li GP
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):417-21. PubMed ID: 19567018
[TBL] [Abstract][Full Text] [Related]
24. Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide.
Tada Y; Yoshikawa T; Shimomura M; Sawada Y; Sakai M; Shirakawa H; Nobuoka D; Nakatsura T
Int J Oncol; 2013 Oct; 43(4):1019-26. PubMed ID: 23903757
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
Yamamoto T; Nagano H; Imai Y; Fukuda K; Matsumoto H; Kondo M; Ota H; Nakamura M; Wada H; Noda T; Damdinsuren B; Dono K; Umeshita K; Nakamori S; Sakon M; Wakasa K; Monden M
Int J Clin Oncol; 2007 Apr; 12(2):150-4. PubMed ID: 17443284
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
Palmer DH; Midgley RS; Mirza N; Torr EE; Ahmed F; Steele JC; Steven NM; Kerr DJ; Young LS; Adams DH
Hepatology; 2009 Jan; 49(1):124-32. PubMed ID: 18980227
[TBL] [Abstract][Full Text] [Related]
27. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.
Cai Z; Su X; Qiu L; Li Z; Li X; Dong X; Wei F; Zhou Y; Luo L; Chen G; Chen H; Wang Y; Zeng Y; Liu X
Mol Cancer; 2021 Dec; 20(1):164. PubMed ID: 34903219
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of hepatocellular carcinoma with extrahepatic metastases.
Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M
J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200
[TBL] [Abstract][Full Text] [Related]
29. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
Yoon HI; Seong J
Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
31. Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.
Kim BK; Ahn SH; Seong JS; Park JY; Kim DY; Kim JK; Lee DY; Lee KH; Han KH
Liver Int; 2011 Mar; 31(3):369-76. PubMed ID: 21083802
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ
J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192
[TBL] [Abstract][Full Text] [Related]
33. Bone metastases from primary hepatocellular carcinoma simulating multiple myeloma.
Doval DC; Bhatia K; Vaid AK; Prabhash K; Jena A; Hazarika D
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):308-10. PubMed ID: 15908337
[TBL] [Abstract][Full Text] [Related]
34. A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.
Abei M; Okumura T; Fukuda K; Hashimoto T; Araki M; Ishige K; Hyodo I; Kanemoto A; Numajiri H; Mizumoto M; Sakae T; Sakurai H; Zenkoh J; Ariungerel G; Sogo Y; Ito A; Ohno T; Tsuboi K
Radiat Oncol; 2013 Oct; 8():239. PubMed ID: 24131485
[TBL] [Abstract][Full Text] [Related]
35. Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma.
Nakagawa H; Mizukoshi E; Kobayashi E; Tamai T; Hamana H; Ozawa T; Kishi H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Muraguchi A; Kaneko S
Gastroenterology; 2017 May; 152(6):1395-1406.e10. PubMed ID: 28188748
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
[TBL] [Abstract][Full Text] [Related]
37. [A case of HCC with portal vein thrombosis treated with multidisciplinary treatment combined with preoperative SBRT and radical resection].
Marubashi S; Gotoh K; Akita H; Takahashi H; Sugimura K; Miyoshi N; Motoori M; Kishi K; Noura S; Ohue M; Fujiwara Y; Yano M; Ishikawa O; Sakon M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2127-9. PubMed ID: 25731445
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
[TBL] [Abstract][Full Text] [Related]
40. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
